Strattera (atomoxetine) is a non-stimulant medication used to treat attention deficit hyperactivity disorder (ADHD) in adults and children over 6 years old. As a selective norepinephrine reuptake inhibitor (SNRI), it works by increasing norepinephrine levels in the brain to improve focus and attention.

Benefits:

• Reduces ADHD symptoms by approximately 25% within one month
• Effects can last up to 24 hours
• Helpful for those with co-occurring conditions like depression, bipolar disorder, or OCD
• Improves quality of life and emotional stability
• Benefits may continue for 6 months after discontinuation

Common Side Effects:

• Dry mouth
• Nausea
• Decreased appetite
• Dizziness
• Constipation
• Urination difficulties
• Sexual side effects (in adults)
• Mood changes (in children)

Comparing to Stimulant Medications:

• Takes longer to work than stimulants
• Generally less effective than stimulants
• Lower risk of cardiovascular problems
• No potential for addiction or abuse
• Longer-lasting effects (up to 24 hours)

Important Considerations:

• Not recommended during pregnancy
• Cannot be taken with MAOIs
• May increase suicide risk in children and adolescents (rare)
• Requires close monitoring when starting treatment
• May cause weight loss rather than weight gain

Strattera offers an effective alternative for ADHD treatment, particularly for those who cannot take stimulants or have a history of substance abuse. While it may take longer to work than stimulant medications, its long-lasting effects and safety profile make it a valuable option for many patients.

Related Articles

Previous Articles